Royce & Associates LP Bridge Bio Pharma, Inc. Transaction History
Royce & Associates LP
- $10.3 Billion
- Q4 2024
A detailed history of Royce & Associates LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 144,788 shares of BBIO stock, worth $5.34 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
144,788
Previous 121,955
18.72%
Holding current value
$5.34 Million
Previous $3.1 Million
27.96%
% of portfolio
0.04%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$931 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$926 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$556 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$459 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$228 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.46B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...